Mary Tagliaferri - Apr 27, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Director
Signature
/s/ Mary Tagliaferri
Stock symbol
ENZ
Transactions as of
Apr 27, 2022
Transactions value $
$0
Form type
4
Date filed
4/29/2022, 04:44 PM
Next filing
Jul 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock, $0.01 Par Value Award $0 +39.1K $0.00 39.1K Apr 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENZ Stock Option (to acquire Common Stock) 77.1K Apr 27, 2022 Common Stock 77.1K $2.63 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units that will vest, subject to the individual continuing to serve as a member of the board of directors of Enzo Biochem, Inc., in two equal annual instalments, beginning on April 27, 2023.
F2 The stock options have a five-year term. Fifty percent of the stock options have vested, and the remaining fifty percent will vest on January 11, 2023.